Potential impact of the COVID-19 pandemic on the national and regional incidence, epidemiology and diagnostic testing of chlamydia and gonorrhoea in Sweden, 2020.


Journal

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
ISSN: 1600-0463
Titre abrégé: APMIS
Pays: Denmark
ID NLM: 8803400

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 25 06 2021
accepted: 31 10 2021
pubmed: 11 11 2021
medline: 24 12 2021
entrez: 10 11 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has challenged the societies and health care systems globally, and resulted in many social and physical distancing restrictions to limit the spread of SARS-CoV-2. These restrictions have also likely affected the frequency of intimate contacts and the spread of sexually transmitted infections (STIs). Compared to most other countries, Sweden especially in Spring-Autumn 2020 pursued mainly milder voluntary, that is, not mandatory enforced by laws, recommended restrictions and the impacts of these on society and spread of STIs remain largely unknown. We describe the potential impact of the COVID-19 pandemic on the national and regional incidence, epidemiology and diagnostic testing of chlamydia and gonorrhoea in Sweden in 2020. Compared to 2019, we found a significant decrease in incidence of chlamydia (-4.5%) and gonorrhoea (-17.5%), and in diagnostic testing (-10.5% for chlamydia, -9.4% for gonorrhoea) in 2020. However, the decrease in chlamydia incidence, which has mainly been decreasing in the last 10 years, was not significant when compared with the average incidence in 2017-2019. The largest decrease in national incidence of both infections was observed among young and heterosexual patients, however, some Swedish regions showed an increased incidence, particularly of chlamydia. Increased "internet-based self-sampling" testing approach partly compensated for a decreased attendance at STI clinics. Studies, including sexual behaviour, prevention, reasons for attending STI health care, STIs in different anatomical sites and management of STIs, are required to elucidate the impact of COVID-19-associated social and physical distancing restrictions on sexual activity and the incidence and epidemiology of chlamydia and gonorrhoea in Sweden.

Identifiants

pubmed: 34758169
doi: 10.1111/apm.13191
pmc: PMC8653056
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

34-42

Informations de copyright

© 2021 The Authors. APMIS published by John Wiley & Sons Ltd on behalf of Scandinavian Societies for Medical Microbiology and Pathology.

Références

Lancet Infect Dis. 2017 Aug;17(8):e235-e279
pubmed: 28701272
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e553-e556
pubmed: 32491214
Sex Transm Dis. 2020 Jul;47(7):434-436
pubmed: 32520878
APMIS. 2021 Jul;129(7):320-323
pubmed: 33622025
Open Forum Infect Dis. 2020 Nov 02;8(1):ofaa536
pubmed: 33506064
Sex Transm Infect. 2020 May;96(3):160-165
pubmed: 31932359
Sex Transm Infect. 2021 Jun;97(4):318
pubmed: 33028650
Sex Transm Infect. 2021 Mar;97(2):99
pubmed: 32796092
Sex Transm Infect. 2021 Mar;97(2):85-87
pubmed: 32967930
APMIS. 2022 Jan;130(1):34-42
pubmed: 34758169
Acta Paediatr. 2020 Dec;109(12):2459-2471
pubmed: 32951258
J Travel Med. 2020 Dec 23;27(8):
pubmed: 32841356
World Med Health Policy. 2021 Jun 03;:
pubmed: 34226854
Sex Transm Infect. 2021 Nov;97(7):549
pubmed: 33397799
Sex Transm Infect. 2021 Dec;97(8):622-623
pubmed: 33574133
J Sex Med. 2020 Aug;17(8):1407-1413
pubmed: 32653391
Public Health Pract (Oxf). 2021 Nov;2:100072
pubmed: 33521735
Sex Transm Infect. 2021 Nov;97(7):550
pubmed: 33397798
Sex Transm Infect. 2021 Mar;97(2):101-102
pubmed: 33132224
Euro Surveill. 2020 Nov;25(47):
pubmed: 33243354
Sex Transm Infect. 2021 Feb;97(1):78
pubmed: 32719105

Auteurs

Katariina Saarentausta (K)

School of Medical Sciences, Örebro University, Örebro, Sweden.
WHO Collaborating Centre for Gonorrhoea and other STIs, National Reference Laboratory for STIs, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Lovisa Ivarsson (L)

Department of Clinical Microbiology, Uppsala University Hospital, Uppsala, Sweden.
Section of Clinical Bacteriology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Susanne Jacobsson (S)

WHO Collaborating Centre for Gonorrhoea and other STIs, National Reference Laboratory for STIs, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Björn Herrmann (B)

Department of Clinical Microbiology, Uppsala University Hospital, Uppsala, Sweden.
Section of Clinical Bacteriology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Martin Sundqvist (M)

WHO Collaborating Centre for Gonorrhoea and other STIs, National Reference Laboratory for STIs, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Magnus Unemo (M)

WHO Collaborating Centre for Gonorrhoea and other STIs, National Reference Laboratory for STIs, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH